Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28M Buy
217,819
+107,142
+97% +$12.5M 0.32% 64
2026
Q1
$11.6M Hold
110,677
0.23% 78
2025
Q4
$11.6M Buy
110,677
+37,158
+51% +$3.49M 0.23% 78
2025
Q3
$6.17M Sell
73,519
-12,411
-14% -$1.02M 0.23% 86
2025
Q2
$6.8M Buy
+85,930
New +$6.83M 0.28% 70
2024
Q4
$3.83M Buy
38,518
+10,212
+36% +$1.05M 0.32% 58
2024
Q3
$3.21M Sell
28,306
-4,790
-14% -$569K 0.41% 52
2024
Q2
$4.1M Buy
33,096
+177
+0.5% +$22.8K 0.72% 32
2024
Q1
$4.34M Sell
32,919
-3,086
-9% -$380K 0.86% 26
2023
Q4
$3.93M Buy
36,005
+22,884
+174% +$2.38M 0.84% 27
2023
Q3
$1.35M Sell
13,121
-6,022
-31% -$649K 0.33% 77
2023
Q2
$2.21M Sell
19,143
-2,066
-10% -$235K 0.53% 41
2023
Q1
$2.26M Buy
21,209
+661
+3% +$71.4K 0.59% 39
2022
Q4
$2.28M Buy
20,548
+39
+0.2% +$3.99K 0.71% 30
2022
Q3
$1.77M Buy
20,509
+3,545
+21% +$316K 0.67% 31
2022
Q2
$1.55M Buy
16,964
+6,702
+65% +$594K 0.6% 34
2022
Q1
$842K Buy
+10,262
New +$809K 0.32% 81

Other funds holding MRK

Vise Technologies's MRK Position: Q2 2026 in Review

Vise Technologies increased its Merck (MRK) stake by 97% in Q2 2026, buying an estimated $12.5M and bringing the position to 217,819 shares worth $28M. The position accounts for 0.32% of the portfolio, ranked #64.

Vise Technologies first reported a position in MRK in Q1 2022 and has held it in 17 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Vise Technologies held 217,819 shares of Merck worth $28M as of Q2 2026.
  • Vise Technologies bought 107,142 Merck shares in Q2 2026, an estimated $12.5M.
  • Merck made up 0.32% of Vise Technologies's portfolio in Q2 2026, its #64 holding.
  • Vise Technologies first reported a position in Merck in Q1 2022 and has held it in 17 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.